期刊文献+

急性冠脉综合征患者血清NT-proBNP、hs-CRP、FBG及Leptin的临床研究 被引量:5

The association of N-terminal pro-brain natriuretic peptide (NT-proBNP),fasting blood glucose(FBG), highsensitive c-reactive protein(hs-CRP) and leptin in patients with acute coronary syndorme(ACS)
暂未订购
导出
摘要 目的 测定急性冠脉综合征(ACS)患者、稳定型心绞痛(SAP)患者及健康人血清N末端B型钠尿肽前体(NT-proBNP)、超敏C-反应蛋白(hs-CRP)、空腹血糖(FBG)及瘦素(Leptin)水平的变化,并探讨其变化的临床意义.方法 选取急性心肌梗死(AMI)患者30例,不稳定型心绞痛(UAP)患者30例,稳定型心绞痛(SAP)患者30例,并选取与之年龄、性别相匹配的30名同期到我院的健康体检者作为正常对照组.测定所有入选对象的血清NT-proBNP、hs-CRP、FBG及Leptin的浓度;对所有入选对象行心脏超声心动图检查,测定左心室射血分数(LVEF)和左心室舒张末期内径(LVEDD).结果 ①AMI组血清NT-proBNP浓度明显高于UAP组、SAP组及正常对照组,差异均有统计学意义(P=0.025,P=0.000,P=0.000).UAP组NT-proBNP浓度明显高于SAP组及正常对照组,差异有统计学意义(P=0.029,P=0.008).SAP组NT-proBNP浓度高于正常对照组,差异有统计学意义(P=0.000).②AMI组血清hs-CRP浓度与UAP组相比,差异无统计学意义(P=0.869),与SAP组及正常对照组相比,差异均有统计学意义(P=0.000,P=0.000).UAP组hs-CRP浓度明显高于SAP组及正常对照组,差异均有统计学意义(P=0.000,P=0.000).③AMI组血清FBG浓度明显高于UAP组、SAP组及正常对照组,差异有统计学意义(P=0.049,P=0.000,P=0.000).UAP组FBG浓度明显高于SAP组及正常对照组,差异有统计学意义(P=0.001,P=0.003).④AMI组血清Leptin浓度与SAP组及正常对照组相比,差异均有统计学意义(P=0.001,P=0.000).UAP组Leptin浓度明显高于SAP组及正常对照组,差异均有统计学意义(P=0.041,P=0.000);SAP组与正常对照组相比,差异有统计学意义(P=0.000).⑤AMI组LVEF值与UAP组相比,差异无统计学意义(P=0.104),明显低于SAP组及正常对照组(P=0.000,P=0.000).UAP组LVEF值明显低于SAP组及正常对照组,差异均有统计学意义(P=0.000,P=0.000),SAP组明显低于正常对照组,差异有统计学意义(P=0.000).结论 ①ACS患者发病早期往往伴有NT-proBNP、hs-CRP、FBG及Leptin水平升高.②ACS患者多伴有心室重塑,往往有LVEDD增大及LVEF值下降. Objective This study addressed to measure serum N-terminal pro-brain natriuretic peptide (NT-proBNP), fasting blood glucose (FBG), highsensitive c-reactive protein (hs-CRP) and leptin concentration in patients with acute coronary syndorme, stable angina pectoris and normal healthy subjeets, and aims to investigate the eorrelation among them, and the clinical signifieance. Methods One hundred and twenty subjects were divided into four groups: 30 patients with acute myocardial infarction, 30 patients with unstable angina pectoris, 30 patients with stable angina pectoris and 30 normal healthy subjects who were matehed with age and sex as con- trol. NT-proBNP, FBG, hs-CRP and leptin's concentration were determined by Biochemistry Laboratory, all the suhjeets were performed to detect left ventricular ejection fraction, left ventrieular diastolic diameter by echoear- diography. According to the levels of the NT-proBNP coneentration, ACS patients were divided into two groups to observe the relationship between the levels of the NT-proBNP and prognosis. Results (1)The serum level of NT- proBNP was higher in AMI patients than those of UAP, and AP, and eontrol subjects (P=0.025, P=0.000, P= 0.000). The serum level of NT-proBNP in UAP patients was higher than SAP, eontrol subjeets (P=O.O29,P= 0.008). SAP patients' level was higher than normal healthy subjects (P=0.000). (2)Compared with AMI patients, the level of hs-CRP in UAP patients has no signifieant difference(P=0.869), but the level of hs-CRP in AMI and UAP patients was increased than SAP and normal subjects (P=0.000,P=0.000). (3)The serum level of FBG was higher in AMI patients than those of UAP, and SAP, and control subjeets (P=0.049, P=0.000, P=0.000). The serum level of FBG in UAP patients was higher than SAP, control subjeets(P=0.001,P=0.003). (4)Compared with AMI patients, the level of leptin in UAP patients has no significant difference (P=0.105), but the level of leptin in AMI patients was increased than SAP and normal subjects (P=0.000,P=0.001). The serum level of leptin in UAP patients was higher than SAP, and control subjeets(P--0.041 ,P=0.000), the level of leptin in SAP and nor- real patients has also significant difference (P=0.O00). (5)The level of LVEF in AMI and UAP has no significant difference (P=0.104), but the level of LVEF in AMI and UAP patients was decreased than SAP and normal sub- jects(P=0.000,P=0.000), the level of LVEF in SAP and normal patients has also significant difference, too(P= 0.000). Conclusion The levels of NT-proBNP were negative correlated with LVEF, were positive correlated with LVDD and hs-CRP, hs-CRP was positive and significantly correlated with NT-proBNP, FBG was positive and significantly correlated with NT-proBNP and Leptin, and LVEDD was negative and signifleantly correlated with LVEF.
出处 《中国心血管病研究》 CAS 2012年第1期28-32,共5页 Chinese Journal of Cardiovascular Research
基金 2009年山东省卫生保健基金项目(项目编号:2007第BW12)
关键词 急性冠脉综合征 血浆N末端B型钠尿肽前体 超敏C-反应蛋白 空腹血糖 瘦素 Acute coronary syndorme NT-proBNP hs-CRP Fasting blood glucose Leptin
  • 相关文献

参考文献18

  • 1Gill D, Seidier T, Troushton RW, et al. Vigorous response in plasma N-terminal pro-brain natriuretic peptide(NT-proBNP) to acute myocardial infarction. Clin Sci, 2004,106:135-139.
  • 2周丽程,郑杨.脑钠素、N-末端脑钠素前体与心血管疾病[J].中国心血管病研究,2007,5(12):937-939. 被引量:11
  • 3Barzilay JI, Abraham L, Heck, bert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes, 2001,50: 2384-2388.
  • 4Hammerer-Leroher A, Neubauer E, Muller S, et al. Head-to-head comparison of N-emlinal pro-brain natriuretic peptide,brain natriuretic peptide and N-terminal Pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Aeta,2001,310:193-197.
  • 5James SK, Lindahl B, Sieg, balln A, et 81. N-terminal Pro-brain natriuretic peptide and other risk markers for the separate predlction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global UtiliZation of Strategies to Open Occluded arteries (GUSTO)- Ivsubstudy. Circulation, 2003,108 : 275-381.
  • 6De Lemos JA, Morrow DA. Combining natriuretic peptide and necrosis markers in the assessment of acute coronary syndromes. Rev Cardiovasc Med, 2003,4: S37-46.
  • 7庄晓峰,许朝祥,杜心清.纤维蛋白原与超敏C-反应蛋白、冠状动脉病变的相关性[J].福建医科大学学报,2006,40(2):150-153. 被引量:35
  • 8倪洪波,翁志远,李大鹏.超敏C反应蛋白在急性冠脉综合征中的改变[J].中国误诊学杂志,2008,8(20):4810-4811. 被引量:10
  • 9沈彬,吴宗贵.不稳定型心绞痛患者超敏C反应蛋白的测定及临床意义[J].上海医学,2004,27(4):234-236. 被引量:28
  • 10Li JJ. Rapid effects on lipid profile and C-reactive protein by simvastatin in patients with hypereholesterolemia. Clin Cardiol, 2003,26 : 472-476.

二级参考文献82

  • 1王贵荣,段永桂,周钧.冠心病患者血中C反应蛋白、纤维蛋白原和白细胞变化及其意义[J].天津医药,2004,32(8):515-516. 被引量:7
  • 2王雪青.纤维蛋白(原)在动脉粥样硬化发病中的作用及机制[J].生理科学进展,1996,27(3):245-248. 被引量:41
  • 3肖春晖,吴小庆,羊镇宇,李肖蓉,王如兴.B型利钠肽与孤立性心房颤动[J].中国循环杂志,2007,22(1):31-34. 被引量:12
  • 4[1]Weber M,Hamm C.Role of B-type natriuretic peptide and NT-proBNP in clinical routine.Heart,2006,92:843-849.
  • 5[2]Mueller C,Scloler A,loule-Kilian K,et al.Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.N Engl J Med,2004,350:647-54.
  • 6[3]Steg PG,Joubin L,Mecord Jet al.B-Type natriuretic peptide and echocardio graphic determination of ejection fractioninthe diagnosis of congestive heart failure in patients with acute dyspnea.CHEST,2005,128:21-29.
  • 7[4]Januzzi JL Jr,Camargo CA,Anwaruddin S,et al.The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.Am J Cardiol,2005,95:948-954.
  • 8[5]Odar-Cederlof I,Bjellerup P,Williams A,et al.Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP),a biomarker of left ventricular dysfunction.Hemodial Int,2006,10:394-398.
  • 9[6]Knebel F,Schimke l,Plief K,et al.NT-ProBNP in acute heart failure:correlation with invasively measured hemodynamic parameters during recompensation.J Card Fail,2005,11(Suppl 5):S38-S41.
  • 10[8]Heart Protection Study Collaborative Group,Emberson JR.N-terminal Pro-B-type natriu retic peptide,vascular disease risk,and cholesterol reduction among 20 536 patients in the MRC/BHF heart protection study.J Am Coll Car diol,2007,49:311-319.

共引文献97

同被引文献30

  • 1赵正源,程庆书,王云杰,刘锟,李文海,陈连宏,王彩霞,齐海妮.多电极高温射频消融治疗肺转移瘤的临床研究[J].临床肿瘤学杂志,2005,10(2):183-185. 被引量:11
  • 2邵亮,李南方.脑利钠肽在临床心血管疾病中的应用进展[J].临床心血管病杂志,2007,23(3):164-166. 被引量:15
  • 3陈瑾,杨新春,王树岩,朱建国,刘秀兰,吴雅峰,张麟.慢性心力衰竭患者心脏β_1受体自身抗体与心功能的相关性及临床意义[J].中华心血管病杂志,2007,35(7):599-602. 被引量:18
  • 4Sabatasso S, Vaucher P, Augsburger M, et al. Sensitivity and specificity of NT-proBNP to detect heart failure at post mortem examination. Int J Legal Med, 2011,125 : 849-856.
  • 5Hartford M, Wiklund O, Mattsson Huhen L, et al. C-reactive protein, interleukin-6, secretory phospholipase A2 group 1I A and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes. J Intern Med, 2007,262 : 526-536.
  • 6陈韬,王晨华.心力衰竭患者尿NT-proBNP的测定及临床意义[J].心血管康复医学杂志,2009;8( 1):56.
  • 7张德炳,张树基.危重急症的诊断与治疗[M].北京:中国科学技术出版社.201i,10M03.
  • 8郭祖超.NT-proBNP检测在心力衰竭中的临床应用[M].北京:人民卫生出版社.2009,171-175.
  • 9Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation, 2005, 111 (23) : 3078-3086.
  • 10Kannel WB, Mcgee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA, 1979, 241 (19) : 2035-2038.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部